Management of advanced or recurrent cervical cancer: chemotherapy and beyond.
about
A new arylbenzofuran derivative functions as an anti-tumour agent by inducing DNA damage and inhibiting PARP activity.Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesionsClinical effects of vinorelbine administration in the management of various malignant tumor types in dogs: 58 cases (1997-2012).Intensity-modulated radiotherapy combined with iodine-125 seed implantation in non-central recurrence of cervical cancer: A case report and literature review.
P2860
Management of advanced or recurrent cervical cancer: chemotherapy and beyond.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Management of advanced or recurrent cervical cancer: chemotherapy and beyond.
@en
type
label
Management of advanced or recurrent cervical cancer: chemotherapy and beyond.
@en
prefLabel
Management of advanced or recurrent cervical cancer: chemotherapy and beyond.
@en
P2860
P1476
Management of advanced or recurrent cervical cancer: chemotherapy and beyond.
@en
P2093
Laurie M Elit
P2860
P304
P356
10.1586/14737140.2014.866041
P577
2014-01-10T00:00:00Z